Fidelity Investments’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$8.77M Buy
121,242
+114,110
+1,600% +$8.84M ﹤0.01% 2212
2026
Q2
$490K Sell
7,132
-288,489
-98% -$16.4M ﹤0.01% 3292
2026
Q1
$19M Sell
295,621
-537,117
-65% -$49M ﹤0.01% 1800
2025
Q4
$108M Buy
832,738
+329,429
+65% +$45.2M 0.01% 1145
2025
Q3
$54.2M Buy
503,309
+339,985
+208% +$37M ﹤0.01% 1407
2025
Q2
$15.1M Sell
163,324
-2,630,629
-94% -$207M ﹤0.01% 1778
2025
Q1
$247M Buy
2,793,953
+2,391,459
+594% +$207M 0.02% 718
2024
Q4
$30.9M Buy
402,494
+348,669
+648% +$24.4M ﹤0.01% 1571
2024
Q3
$2.28M Buy
53,825
+40,219
+296% +$1.36M ﹤0.01% 2359
2024
Q2
$356K Sell
13,606
-200
-1% -$3.79K ﹤0.01% 2846
2024
Q1
$126K Sell
13,806
-8
-0.1% -$48 ﹤0.01% 3193
2023
Q4
$38K Buy
13,814
+8,946
+184% +$20.8K ﹤0.01% 3642
2023
Q3
$17.7K Buy
4,868
+4,410
+963% +$24.2K ﹤0.01% 3867
2023
Q2
$2.73K Sell
458
-859
-65% -$6.8K ﹤0.01% 4519
2023
Q1
$15.9K Buy
1,317
+967
+276% +$12.9K ﹤0.01% 3942
2022
Q4
$3.05K Buy
350
+320
+1,067% +$7.05K ﹤0.01% 4404
2022
Q3
$858 Sell
30
-8,349
-100% -$382K ﹤0.01% 4726
2022
Q2
$348K Buy
8,379
+34
+0.4% +$2.31K ﹤0.01% 2954
2022
Q1
$845K Sell
8,345
-37,924
-82% -$4.22M ﹤0.01% 2822
2021
Q4
$6.81M Sell
46,269
-8,334
-15% -$1.86M ﹤0.01% 2268
2021
Q3
$13.7M Buy
+54,603
New +$18.8M ﹤0.01% 1991

Other funds holding WGS

Fidelity Investments's WGS Position: Q3 2026 in Review

Fidelity Investments increased its GeneDx Holdings (WGS) stake by 1,600% in Q3 2026, buying an estimated $8.84M and bringing the position to 121,242 shares worth $8.77M. The position accounts for ﹤0.01% of the portfolio, ranked #2212.

Fidelity Investments first reported a position in WGS in Q3 2021 and has held it in 21 quarters since. The position peaked at $247M in Q1 2025. 97 funds tracked by Wall St. Rank hold WGS as of Q3 2026.

  • Fidelity Investments held 121,242 shares of GeneDx Holdings worth $8.77M as of Q3 2026.
  • Fidelity Investments bought 114,110 GeneDx Holdings shares in Q3 2026, an estimated $8.84M.
  • GeneDx Holdings made up ﹤0.01% of Fidelity Investments's portfolio in Q3 2026, its #2212 holding.
  • Fidelity Investments first reported a position in GeneDx Holdings in Q3 2021 and has held it in 21 quarters since.
  • Fidelity Investments's GeneDx Holdings position peaked at $247M in Q1 2025.
  • 97 funds tracked by Wall St. Rank held GeneDx Holdings as of Q3 2026.

Based on Fidelity Investments's 13F filing for Q3 2026, filed 10 Nov 2026.